Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1,071 | 2 | 45.8% |
| Food and Beverage | $947.62 | 30 | 40.5% |
| Travel and Lodging | $286.76 | 1 | 12.3% |
| Education | $24.00 | 1 | 1.0% |
| Gift | $10.36 | 1 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $1,071 | 2 | $0 (2020) |
| Covidien LP | $329.89 | 2 | $0 (2017) |
| AbbVie, Inc. | $226.26 | 10 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $121.87 | 1 | $0 (2022) |
| Mirum Pharmaceuticals, Inc. | $118.14 | 1 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $111.64 | 1 | $0 (2018) |
| Lupin Pharmaceuticals, Inc | $89.31 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $68.00 | 6 | $0 (2018) |
| Prometheus Laboratories Inc. | $49.80 | 2 | $0 (2018) |
| Ethicon Inc. | $45.52 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $118.14 | 1 | Mirum Pharmaceuticals, Inc. ($118.14) |
| 2022 | $121.87 | 1 | Regeneron Healthcare Solutions, Inc. ($121.87) |
| 2020 | $610.95 | 3 | Eli Lilly and Company ($579.22) |
| 2019 | $491.62 | 1 | Eli Lilly and Company ($491.62) |
| 2018 | $321.87 | 9 | AbbVie, Inc. ($128.45) |
| 2017 | $675.13 | 20 | Covidien LP ($329.89) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/14/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $118.14 | General |
| Category: Alagille syndrome | ||||||
| 11/10/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/15/2020 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $12.87 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/03/2020 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $18.86 | General |
| Category: THERAPY FOR CSID | ||||||
| 01/25/2020 | Eli Lilly and Company | — | — | In-kind items and services | $579.22 | Research |
| Study: MULTICENTER, OPEN-LABEL PK STUDY OF MIRIKIZUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS | ||||||
| 12/19/2019 | Eli Lilly and Company | — | — | In-kind items and services | $491.62 | Research |
| Study: MULTICENTER, OPEN-LABEL PK STUDY OF MIRIKIZUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS | ||||||
| 12/07/2018 | Prometheus Laboratories Inc. | — | Education | In-kind items and services | $24.00 | General |
| 04/23/2018 | Avanos Medical | MIC-KEY (Device) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: DIGESTIVE HEALTH | ||||||
| 04/04/2018 | Janssen Scientific Affairs, LLC | SIMPONI (Biological) | Food and Beverage | In-kind items and services | $111.64 | General |
| Category: Immunology | ||||||
| 04/03/2018 | AbbVie, Inc. | Humira (Biological), Humira | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Immunology | ||||||
| 03/05/2018 | Janssen Biotech, Inc. | REMICADE (Biological) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Immunology | ||||||
| 02/27/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Immunology | ||||||
| 02/27/2018 | Romark Laboratories, LC | Alinia Tablets 500mg 30 count bottle (Drug), Alinia for Oral Suspension, Alinia Tablets 500mg 12 count bottle | Gift | Cash or cash equivalent | $10.36 | General |
| Category: Gastroenterology | ||||||
| 02/26/2018 | Alexion Pharmaceuticals, Inc. | Kanuma (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Immunology | ||||||
| 01/31/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $95.90 | General |
| Category: Immunology | ||||||
| 12/12/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Immunology | ||||||
| 11/14/2017 | Prometheus Laboratories Inc. | — | Food and Beverage | In-kind items and services | $25.80 | General |
| 10/31/2017 | Janssen Biotech, Inc. | REMICADE (Biological) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Immunology | ||||||
| 10/10/2017 | Janssen Biotech, Inc. | REMICADE (Biological) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: Immunology | ||||||
| 10/03/2017 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $1.74 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/19/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Immunology | ||||||
| 07/25/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Immunology | ||||||
| 06/14/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $13.24 | General |
| 05/10/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Immunology | ||||||
| 05/09/2017 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, STELARA | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MULTICENTER, OPEN-LABEL PK STUDY OF MIRIKIZUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS | Eli Lilly and Company | $1,071 | 2 |
About Dr. Nicholas Ogunmola, MD
Dr. Nicholas Ogunmola, MD is a Pediatric Gastroenterology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578669743.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Ogunmola, MD has received a total of $2,340 in payments from pharmaceutical and medical device companies, with $118.14 received in 2024. These payments were reported across 35 transactions from 16 companies. The most common payment nature is "" ($1,071).
Practice Information
- Specialty Pediatric Gastroenterology
- Location Fort Worth, TX
- Active Since 09/15/2006
- Last Updated 05/05/2021
- Taxonomy Code 2080P0206X
- Entity Type Individual
- NPI Number 1578669743
Products in Payments
- Barrx (Device) $329.89
- Humira (Biological) $213.02
- DUPIXENT (Biological) $121.87
- Livmarli (Drug) $118.14
- SIMPONI (Biological) $111.64
- Suprax (Drug) $89.31
- REMICADE (Biological) $57.40
- LINX Reflux Management System (Device) $45.52
- Sucraid (Drug) $33.47
- Kanuma (Drug) $18.24
- MIC-KEY (Device) $17.21
- Karbinal ER (Drug) $15.32
- ACTIMMUNE (Drug) $13.71
- STELARA (Biological) $10.60
- Alinia Tablets 500mg 30 count bottle (Drug) $10.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Gastroenterology Doctors in Fort Worth
Dr. Clifton Huang, Md, MD
Pediatric Gastroenterology — Payments: $46,277
Bankole Osuntokun, Md, MD
Pediatric Gastroenterology — Payments: $2,038
Sherief Mansi, Md, MD
Pediatric Gastroenterology — Payments: $1,060
Samson Cantu, M.d, M.D
Pediatric Gastroenterology — Payments: $826.94
Lyn Hunt, Md, MD
Pediatric Gastroenterology — Payments: $306.24